Mineralys Therapeutics, Inc. (MLYS) Operating income 2022–2025
Mineralys Therapeutics, Inc. (MLYS) annual operating income history from SEC filings — each fiscal year as reported.
-$170.6MFY2025 · since FY2022: -$31.5M → -$170.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$170.6M | +11.3% |
| FY2024 | -$192.4M | -127.3% |
| FY2023 | -$84.7M | -168.9% |
| FY2022 | -$31.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice